Regarding parasitic infections, the administration of α-GalCer with different Plasmodium spp.-derived antigens has been demonstrated to elicit both IFN-γ production and malaria-specific CD4+ T cells, leading to an increased anti-malaria immunity in mice [125]. The gene discussed is IFNG; the disease is malaria.